SCHEMBL26075350

SCHEMBL26075350

CCCCOc1ccc(-c2ccc(-c3cc(C=O)c4cc(F)ccc4n3)cc2F)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.44
▸ DHODH Q02127 4/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ RARA P10276 1/20 0.39
▸ RARB P10826 1/20 0.39
▸ KCNH2 Q12809 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ XDH P47989 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PDE2A O00408 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075352 0.96 DHODH (0.45) PLA2G2ADHODHPDE10A
SCHEMBL26075343 0.92 PLA2G2A (0.39) PLA2G2ADHODHPDE10ARARARARB
SCHEMBL26075330 0.91 PLA2G2A (0.41) PLA2G2ADHODHPDE10AKCNH2HRH3
SCHEMBL26075357 0.89 PLA2G2A (0.42) PLA2G2ADHODHPDE10ARARARARB
SCHEMBL26075237 0.89 PLA2G2A (0.44) PLA2G2ADHODHPDE10ARARARARB
SCHEMBL26075365 0.89 PLA2G2A (0.41) PLA2G2ADHODHPDE10ARARARARB
SCHEMBL26075362 0.89 PLA2G2A (0.41) PLA2G2ADHODHPDE10ARARARARB
SCHEMBL26075354 0.89 PLA2G2A (0.41) PLA2G2ADHODHPDE10ARARARARB
SCHEMBL26075360 0.89 PLA2G2A (0.41) PLA2G2ADHODHPDE10ARARARARB
SCHEMBL26075277 0.87 PLA2G2A (0.42) PLA2G2ADHODHPDE10AKCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD PLA2G2A 1679/4885DHODH 1/4885PDE10A 3462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback